Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.4214
Delayed Data
As of 3:58pm ET
 -0.0105 / -2.43%
Today’s Change
0.29
Today|||52-Week Range
0.85
-33.90%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Goldberg Michael M
President & Chief Executive Officer
Sale1/17/20175,411,850$0.01$54.1K-29.21%
Goldberg Michael M
President & Chief Executive Officer
Gift5/16/2017106,021$0.46$48.8K-6.11%
Cope Frederick O
Chief Scientific Officer & Senior Vice President
Gift2/06/201788,378$0.52$46.0K-16.93%
Regan William J
Chief Compliance Officer & Senior Vice President
Gift2/06/201779,155$0.52$41.2K-16.93%
Klima Thomas J
Chief Commercial Officer & Senior Vice President
Gift2/06/201750,885$0.52$26.5K-16.93%
Regan William J
Senior Vice President
Buy6/29/201720,000$0.53$10.6K-16.18%
Greene Mark I
Director
Gift1/10/201716,406$0.64$10.5K-32.38%
Latkin Jed Andrew
Chief Operating & Financial Officer
Buy5/19/201714,159$0.45$6.4K-5.16%
Latkin Jed Andrew
Chief Operating & Financial Officer
Gift5/17/201713,300$0.47$6.3K-5.37%
Latkin Jed Andrew
Chief Operating & Financial Officer
Buy5/22/201711,200$0.45$5.0K-3.92%
Page of 2